. American-psychiatric-association, Diagnostic and statistical manual of mental disorders DSM-4-TR (4e éd. Rev.), 2000.

A. Lobo, L. Launer, L. Fratiglioni, K. Andersen, D. Carlo et al., Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group, Neurology, vol.54, issue.11 5, pp.4-9, 2000.

H. Ramaroson, C. Helmer, P. Barberger-gateau, L. Letenneur, and J. Dartigues, Prévalence de la démence et de la maladie d'Alzheimer chez les personnes de 75 ans et plus: données réactualisées de la cohorte Paquid, Rev Neurol Paris, vol.159, issue.4, pp.405-416, 2003.

A. Aouba, M. Eb, G. Rey, G. Pavillon, and E. Jougla, Données sur la mortalité en France: principales causes de décès en, Bull Epidémiol, 2000.

A. Wilmo and M. Prince, The Global Economic Impact of Dementia. Alzheimer's Disease International, World Alzheimer Report, p.56, 2010.

P. Verger, É. La-politique-du-médicament-en, and . Internet, Ministère de affaires sociales et de la santé; 2013 p. 125 Available from

. Maladie-d-', Alzheimer et maladies apparentées: diagnostic et prise en charge. HAS, Recommandations de bonne pratique, 2011.

L. Médicaments-de-la-maladie-d, Alzheimer à visée symptomatique en pratique quotidienne. HAS, Bon usage des médicaments, 2009.

G. Selbaek, Ø. Kirkevold, and K. Engedal, The prevalence of psychiatric symptoms and behavioural disturbances and the use of psychotropic drugs in Norwegian nursing homes, International Journal of Geriatric Psychiatry, vol.13, issue.9, pp.843-852, 2007.
DOI : 10.1002/gps.1749

H. , R. De-bonne-pratique-vellas, B. Gauthier, S. Allain, H. Andrieu et al., 12 Consensus statement on severe dementia, Rev Neurol, vol.161, pp.8-9868, 2005.

A. Gillioz, H. Villars, P. Malo, G. Silvestre, and P. Jouanny, Quels freins à la recherche clinique sur la démence sévère? Psychol Neuropsychiatr Vieil, pp.193-202, 2010.

B. Winblad and N. Poritis, Memantine in severe dementia: results of the9M-best study (benefit and efficacy in severly demented patients during treatment with memantine), International Journal of Geriatric Psychiatry, vol.296, issue.2, pp.135-181, 1999.
DOI : 10.1002/(SICI)1099-1166(199902)14:2<135::AID-GPS906>3.0.CO;2-0

S. Mitchell, J. Teno, and D. Kiely, The Clinical Course of Advanced Dementia, New England Journal of Medicine, vol.361, issue.16, pp.1529-1567, 2009.
DOI : 10.1056/NEJMoa0902234

M. Panisset, M. Roudier, J. Saxton, and F. Boller, Severe impairment battery. A neuropsychological test for severely demented patients, Arch Neurol, 1994.

B. Reisberg, S. Ferris, M. De-leon, and T. Crook, The Global Deterioration Scale for assessment of primary degenerative dementia, Am J Psychiatry, 1982.

D. Galasko, F. Schmitt, R. Thomas, J. S. Bennett, and D. , Detailed assessment of activities of daily living in moderate to severe Alzheimer's disease, Journal of the International Neuropsychological Society, vol.11, issue.04, pp.446-53, 2005.
DOI : 10.1017/S1355617705050502

J. Morris, The Clinical Dementia Rating (CDR): Current version and scoring rules, Neurology, vol.43, issue.11, pp.2412-2416, 1993.
DOI : 10.1212/WNL.43.11.2412-a

P. Aalten, F. Verhey, M. Boziki, R. Bullock, E. Byrne et al., Neuropsychiatric Syndromes in Dementia, Dementia and Geriatric Cognitive Disorders, vol.24, issue.6, pp.457-63, 2007.
DOI : 10.1159/000110738

L. Schneider, P. Tariot, K. Dagerman, S. Davis, J. Hsiao et al., Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimer's Disease, New England Journal of Medicine, vol.355, issue.15, pp.1525-1563, 2006.
DOI : 10.1056/NEJMoa061240

L. Schneider, K. Dagerman, and P. Insel, Risk of Death With Atypical Antipsychotic Drug Treatment for Dementia, JAMA, vol.294, issue.15, pp.1934-1977, 2005.
DOI : 10.1001/jama.294.15.1934

G. Onder, R. Liperoti, A. Foebel, D. Fialova, E. Topinkova et al., Polypharmacy and Mortality Among Nursing Home Residents With Advanced Cognitive Impairment: Results From the Shelter Study, Journal of the American Medical Directors Association, vol.14, issue.6, pp.450-457
DOI : 10.1016/j.jamda.2013.03.014

H. Alanen, H. Finne-soveri, D. Fialova, E. Topinkova, P. Jonsson et al., Use of antipsychotic medications in older home-care patients. Report from nine European countries, Aging Clinical and Experimental Research, vol.17, issue.3, pp.260-265, 2008.
DOI : 10.1007/BF03324781

A. Gruber-baldini, B. Stuart, I. Zuckerman, L. Simoni-wastila, and R. Miller, Treatment of Dementia in Community-Dwelling and Institutionalized Medicare Beneficiaries, Journal of the American Geriatrics Society, vol.7, issue.10, pp.1508-1524, 2007.
DOI : 10.1111/j.1532-5415.2007.01387.x

K. Tifratene, L. Duff, F. Pradier, C. Quetel, J. Lafay et al., Use of drug treatments for Alzheimer's disease in France: a study on a national level based on the National Alzheimer's Data Bank

L. Fratiglioni, Y. Forsell, A. Torres, H. Winblad, and B. , Severity of Dementia and Institutionalization in the Elderly: Prevalence Data from an Urban Area in Sweden, Neuroepidemiology, vol.13, issue.3, pp.79-88, 1994.
DOI : 10.1159/000110363

J. Tjia, M. Rothman, D. Kiely, M. Shaffer, H. Holmes et al., Daily Medication Use in Nursing Home Residents with Advanced Dementia, Journal of the American Geriatrics Society, vol.63, issue.5, pp.880-888, 2010.
DOI : 10.1111/j.1532-5415.2010.02819.x

C. Helmer, P. Joly, L. Letenneur, D. Commenges, and J. Dartigues, Mortality with Dementia: Results from a French Prospective Community-based Cohort, American Journal of Epidemiology, vol.154, issue.7, pp.642-650, 2001.
DOI : 10.1093/aje/154.7.642

H. Holmes, G. Sachs, and S. Jweta, Integrating palliative medicine intothe care of persons with advanced dementia: Identifying appropriate medication use

J. Dartigues and . «rapport-sur-la-maladie-d, Alzheimer et les maladies apparentées», étude réalisée par l'Institut de santé publique d'épidémiologie et de développement (ISPED) de l'Université Victor Ségalen Bordeaux 2, Office Parlementaire d'évaluation des politiques de santé, Reisberg B, vol.35, 2005.

P. Tariot, M. Farlow, G. Grossberg, S. Graham, S. Mcdonald et al., Memantine Treatment in Patients With Moderate to Severe Alzheimer Disease Already Receiving Donepezil, JAMA, vol.291, issue.3, pp.317-341, 2004.
DOI : 10.1001/jama.291.3.317

S. Black, R. Doody, H. Li, T. Mcrae, K. Jambor et al., Donepezil preserves cognition and global function in patients with severe Alzheimer disease, Neurology, vol.69, issue.5, pp.459-69, 2007.
DOI : 10.1212/01.wnl.0000266627.96040.5a

G. Small, D. Mcdonnell, R. Brooks, and G. Papadopoulos, The Impact of Symptom Severity on the Cost of Alzheimer's Disease, Journal of the American Geriatrics Society, vol.55, issue.2, 2002.
DOI : 10.1016/0895-4356(95)00507-2

K. Yaffe, Patient and Caregiver Characteristics and Nursing Home Placement in Patients With Dementia, JAMA, vol.287, issue.16, pp.2090-2132, 2002.
DOI : 10.1001/jama.287.16.2090

B. Pollock, B. Mulsant, J. Rosen, R. Sweet, S. Mazumdar et al., Comparison of Citalopram, Perphenazine, and Placebo for the Acute Treatment of Psychosis and Behavioral Disturbances in Hospitalized, Demented Patients, American Journal of Psychiatry, vol.159, issue.3, pp.460-465, 2002.
DOI : 10.1176/appi.ajp.159.3.460

S. Gonfrier, S. Andrieu, D. Renaud, B. Vellas, and P. Robert, Course of neuropsychiatric symptoms during a 4-year follow up in the REAL-FR cohort, The journal of nutrition, health & aging, vol.28, issue.1, pp.134-141, 2012.
DOI : 10.1007/s12603-011-0147-9

C. Lai and D. Arthur, Wandering behaviour in people with dementia, Journal of Advanced Nursing, vol.187, issue.1, pp.173-82, 2003.
DOI : 10.1002/1099-1166(200011)15:11<1013::AID-GPS226>3.3.CO;2-O

M. Folstein, S. Folstein, and P. Mchugh, ???Mini-mental state???, Journal of Psychiatric Research, vol.12, issue.3, pp.189-98, 1975.
DOI : 10.1016/0022-3956(75)90026-6

O. Connor, D. Pollitt, P. Hyde, J. Fellows, J. Miller et al., The reliability and validity of the mini-mental state in a British community survey, Journal of Psychiatric Research, vol.23, issue.1, pp.87-96, 1989.
DOI : 10.1016/0022-3956(89)90021-6